From concept to practice: Screening for fetal and neonatal alloimmune thrombocytopenia (FNAIT)
Open Access
- 27 October 2025
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 103, 102683
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort studyThe Lancet Haematology, 2022
- New developments in fetal and neonatal alloimmune thrombocytopeniaAmerican Journal of Obstetrics and Gynecology, 2021
- Recent advances in non-invasive fetal HPA-1a typingTransfusion and Apheresis Science, 2020
- Foetal and neonatal alloimmune thrombocytopenia – The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcomeTransfusion and Apheresis Science, 2020
- Fetal and neonatal alloimmune thrombocytopenia – The Norwegian management modelTransfusion and Apheresis Science, 2020
- Epidemiology and management of fetal and neonatal alloimmune thrombocytopeniaTransfusion and Apheresis Science, 2020
- Progress and development of platelet antibody detectionTransfusion and Apheresis Science, 2020
- Foetal and neonatal alloimmune thrombocytopeniaBest Practice & Research Clinical Obstetrics & Gynaecology, 2019
- Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopeniaAmerican Journal of Hematology, 2019
- Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIGEuropean Journal of Pediatrics, 2006